Journal of Neurology

, Volume 252, Issue 10, pp 1279–1279 | Cite as

Transcatheter patent foramen ovale closure

Identifying the ideal candidate according to the available evidence
LETTER TO THE EDITORS
  • 34 Downloads

References

  1. 1.
    Ago T, Ooboshi H, Kitazono T, et al. (2004) Brain infarction associated with antiphospholipid antibody syndrome caused by paradoxical embolism through patent foramen ovale. J Neurol 251:757–759CrossRefPubMedGoogle Scholar
  2. 2.
    Thomas HR (2001) Hypercoagulability syndromes. Arch Intern Med 161:2433–2439CrossRefPubMedGoogle Scholar
  3. 3.
    Chaturvedi S (1998) Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale. J Neurol Sci 160:158–160CrossRefPubMedGoogle Scholar
  4. 4.
    Mohr JP, Thompson JLP, Lazar RM, et al. (2001) A Comparison ofWarfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke. N Engl J Med 345:1444–1451CrossRefPubMedGoogle Scholar
  5. 5.
    Windecker S, Wahl A, Nedeltchev K, et al. (2004) Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 44:750–758CrossRefPubMedGoogle Scholar
  6. 6.
    Giardini A, Donti A, Formigari R, et al. (2004) Comparison of Results of Percutaneous Closure of Patent Foramen Ovale for Paradoxical Embolism in Patients With-vs-Without Thrombophilia. Am J Cardiol 94:1012–1016CrossRefPubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2005

Authors and Affiliations

  1. 1.Pediatric Cardiology and Adult Congenital UnitUniversity of BolognaBolognaItaly

Personalised recommendations